SCHEMBL26007482

SCHEMBL26007482

CC(C)NCCc1ccc2c(c1)oc1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 7/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 2/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MME P08473 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP2C9 P11712 1/20 0.46
GAA P10253 1/20 0.46
AHR P35869 2/20 0.44
HIF1A Q16665 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19768725 0.80 CYP1A2 (0.57) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL9764810 0.80 CYP1A2 (0.50) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL21510705 0.79 CYP1A2 (0.53) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL25764592 0.78 ECE1 (0.54) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL28263509 0.76 CYP1A2 (0.58) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL30810814 0.75 AHR (0.53) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL10306815 0.75 AHR (0.53) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL21859396 0.75 CYP1A2 (0.53) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL22879786 0.73 ECE1 (0.47) ECE1CYP1A2CYP2C19CYP2D6MEN1
SCHEMBL28218524 0.73 SIGMAR1 (0.50) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME ORC3, PIEZO1, OR10J3 ECE1 62/4885CYP1A2 588/4885CYP2C19 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.